France, Ireland, and Belgium Are the Major Producers on the European Vaccines Market

Pharmaceuticals, Medicinal Chemical And Botanical Products July 12, 2018
EU - Vaccines For Human Medicine - Market Analysis, Forecast, Size, Trends and Insights

Format: Electronic (pdf) by email (February 01, 2019)

Limited Time Offer




Pricing Plan
By clicking «Buy the Report», you agree to our terms of service and privacy policy. We’ll occasionally send you account related emails.
Abstract
Description
Table of Contents

IndexBox has just published a new report "EU: Vaccines For Human Medicine - Market Report. Analysis And Forecast To •••". Here is a summary of the report’s key findings.

The Consumption of Vaccines for Human Medicine Is about ••• Billion EUR

In 2016, EU vaccines for human medicine market was at ••• billion EUR, which was ••• million EUR (or •••%) less than the year before. There was a significant growth by •••% in 2015 due to price increase, after a fluctuations in market volume with an overall upward trend.

France and the UK Were Key Consumers of Vaccines for Human Medicine

The countries with the highest consumption were France (•••% of total consumption), the U.K. (•••%), Germany (•••%), Italy (•••%), Poland (•••%) and Spain (•••%), together comprising near •••% of EU consumption. 

The highest annual growth rates of vaccines for human medicine consumption from 2007 to 2016 were recorded in the U.K., with +•••% growth. Following significant consumtion growth rates, the U.K. sighnificantly strengthened its share in terms of the EU consumption from •••% in 2007 to •••% in 2016. By contrast, shares of Germany (-••• percentage points) declined over the period under review.

Among the leading consuming countries high levels of per capita consumption levels were recorded in France (••• EUR/year in 2016) and the U.K. (••• EUR/year) were significantly higher thah the world average of ••• EUR/year. 

The Growth in Vaccine Consumption Is Expected to Continue against the Backdrop of the Development of the Health System and Immunization Programs in the EU

Vaccine consumption is mainly formed by state programs for the immunization of the population within the health system. Procurement of vaccines is carried out through special state agencies, and the admission of drugs to the market is strictly regulated by national and international legislation.

Since vaccination plays a crucial role in the health system, and immunization programs in the EU will remain relevant, the demand for vaccines will remain stable. Therefore, it is expected to maintain the current trend of market growth in the medium term. The CAGR of + •••% for the nine-year period from 2016 to •••, which is projected to lead the market value to approx. ••• million EUR by the end of •••.

Vaccines Production Peaked in 2016 at Approx. ••• Billion USD

Production of vaccines stood near ••• billion EUR in 2016, indicating mixed trend patterns over the last few years. A robust increase over the period from 2009 to 2011 was followed by a gradual decline from 2010-2014. In 2015, however, the EU production soared rapidly and then leveled off in the following year.

France, Ireland, and Belgium Comprised the Majority of Vaccines Output

According to the estimates, the output of the three major producers of vaccines, namely France, Ireland, and Belgium, represent more than three-quaters of EU vaccines output. All the major vaccines manufacturing countries enjoyed a pronounced growth in the output figures. Particularly high were the growth levels in Ireland (+•••%) and France (+•••%).

Among EU Members Belgium, France, Ireland and the UK Were the Major Exporting Countries

In 2016, the total exports value for vaccines for human medicine was ••• million EUR, •••% less than the year before. In 2016, Belgium (•••%), France (•••%), Ireland (•••%) and the UK (•••%) were the main suppliers of vaccines for human medicine in the EU, comprising •••% of total exports. 

Among main exporting countries in EU, Ireland (from •••% in 2007 to •••% in 2016) significantly strengthened position in terms of the EU exports, while the shares of other countries showed negative dynamics (excluding the UK and the Netherlands, which remained relatively stable throughout the analyzed period).

Belgium, the UK and France Were the Main Consumers of Vaccines in the EU

In 2016, the total imports value stood at ••• million EUR, •••% less than the year before. From 2007 to 2015, EU vaccines for human medicine imports illustrated an upward trend until 2016, when imports of vaccines for human medicine has fallen dramatically.

In 2016, the main import destinations for vaccines for human medicine were Belgium (•••%), the UK (•••%) and France (•••%). The share exported to the UK decreased, while the share of Belgium illustrated a positive dynamic from 2007 to 2016.

Do you want to know more about the European vaccine market? Get the latest trends and insight from our report. It includes a wide range of statistics on

  • vaccine market share
  • vaccine prices
  • vaccine industry
  • vaccine sales
  • vaccine import
  • vaccine export
  • vaccine market forecast
  • vaccine price forecast
  • key vaccine producers

Source: EU: Vaccines For Human Medicine - Market Report. Analysis And Forecast To •••

Product coverage: vaccines for human medicine.

This report provides an in-depth analysis of the vaccine market in the EU. Within it, you will discover the latest data on market trends and opportunities by country, consumption, production and price developments, as well as the global trade (imports and exports). The forecast exhibits the market prospects through 2025.

Country coverage: Austria, Belgium, Bulgaria, Croatia, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Netherlands, Poland, Portugal, Romania , Slovakia, Slovenia, Spain, Sweden, United Kingdom.

Data coverage:
• Vaccine market volume and value;
• Per Capita consumption;
• Forecast of the market dynamics in the medium term;
• Vaccine production in the EU, split by region and country;
• Vaccine trade (exports and imports) in the EU;
• Export and import prices for vaccines for human medicine;
• Vaccine market trends, drivers and restraints;
• Key market players and their profiles.

Reasons to buy this report:
• Take advantage of the latest data;
• Find deeper insights into current market developments;
• Discover vital success factors affecting the market.

This report is designed for manufacturers, distributors, importers, and wholesalers, as well as for investors, consultants and advisors.

In this report, you can find information that helps you to make informed decisions on the following issues

1. How to diversify your business and benefit from new market opportunities
2. How to load your idle production capacity
3. How to boost your sales on overseas markets
4. How to increase your profit margins
5. How to make your supply chain more sustainable
6. How to reduce your production and supply chain costs
7. How to outsource production to other countries
8. How to prepare your business for global expansion

While doing this research, we combine the accumulated expertise of our analysts and the capabilities of artificial intelligence. The AI-based platform, developed by our data scientists, constitutes the key working tool for business analysts, empowering them to discover deep insights and ideas from the marketing data.
1. INTRODUCTION
Making Data-Driven Decisions to Grow Your Business
1.1 REPORT DESCRIPTION
1.2 RESEARCH METHODOLOGY AND AI PLATFORM
1.3 DATA-DRIVEN DECISIONS FOR YOUR BUSINESS
1.4 GLOSSARY AND SPECIFIC TERMS

2. EXECUTIVE SUMMARY
A Quick Overview of Market Performance
2.1 KEY FINDINGS
2.2 MARKET TRENDS

3. MARKET OVERVIEW
Understanding the Current State of The Market and Its Prospects
3.1 MARKET SIZE
3.2 CONSUMPTION BY COUNTRY
3.3 MARKET FORECAST TO 2025

4. MOST PROMISING PRODUCTS
Finding New Products to Diversify Your Business
NOTE: THIS CHAPTER IS AVAILABLE ONLY FOR PROFESSIONAL EDITION
4.1 TOP PRODUCTS TO DIVERSIFY YOUR BUSINESS
4.2 BEST-SELLING PRODUCTS
4.3 MOST CONSUMED PRODUCT
4.4 MOST TRADED PRODUCT
4.5 MOST PROFITABLE PRODUCT FOR EXPORT

5. MOST PROMISING SUPPLYING COUNTRIES
Choosing the Best Countries to Establish Your Sustainable Supply Chain
NOTE: THIS CHAPTER IS AVAILABLE ONLY FOR PROFESSIONAL EDITION
5.1 TOP COUNTRIES TO SOURCE YOUR PRODUCT
5.2 TOP PRODUCING COUNTRIES
5.3 TOP EXPORTING COUNTRIES
5.4 LOW-COST EXPORTING COUNTRIES

6. MOST PROMISING OVERSEAS MARKETS
Choosing the Best Countries to Boost Your Exports
NOTE: THIS CHAPTER IS AVAILABLE ONLY FOR PROFESSIONAL EDITION
6.1 TOP OVERSEAS MARKETS FOR EXPORTING YOUR PRODUCT
6.2 TOP CONSUMING MARKETS
6.3 UNSATURATED MARKETS
6.4 TOP IMPORTING MARKETS
6.5 MOST PROFITABLE MARKETS

7. PRODUCTION
The Latest Trends and Insights into The Industry
7.1 PRODUCTION VOLUME AND VALUE
7.2 PRODUCTION BY COUNTRY

8. IMPORTS
The Largest Importers on The Market and How They Succeed
8.1 IMPORTS FROM 2007–2017
8.2 IMPORTS BY COUNTRY
8.3 IMPORT PRICES BY COUNTRY

9. EXPORTS
The Largest Exporters on The Market and How They Succeed
9.1 EXPORTS FROM 2007–2017
9.2 EXPORTS BY COUNTRY
9.3 EXPORT PRICES BY COUNTRY

10. PROFILES OF MAJOR PRODUCERS
The Largest Producers on The Market and Their Profiles
NOTE: THIS CHAPTER IS AVAILABLE ONLY FOR PROFESSIONAL EDITION

11. COUNTRY PROFILES
The Largest Markets And Their Profiles
NOTE: THIS CHAPTER IS AVAILABLE ONLY FOR PROFESSIONAL EDITION

LIST OF TABLES
Table 1: Key Findings In 2017
Table 2: Market Volume, In Physical Terms, 2007–2017
Table 3: Market Value, 2007–2017
Table 4: Per Capita Consumption, By Country, 2015-2017
Table 5: Production, In Physical Terms, By Country, 2007–2017
Table 6: Imports, In Physical Terms, By Country, 2007–2017
Table 7: Imports, In Value Terms, By Country, 2007–2017
Table 8: Import Prices, By Country Of Destination, 2007–2017
Table 9: Exports, In Physical Terms, By Country, 2007–2017
Table 10: Exports, In Value Terms, By Country, 2007–2017
Table 11: Export Prices, By Country Of Origin, 2007–2017

LIST OF FIGURES
Figure 1: Market Volume, In Physical Terms, 2007–2017
Figure 2: Market Value, 2007–2017
Figure 3: Consumption, By Country, 2017
Figure 4: Market Forecast To 2025
Figure 5: Products: Market Size And Growth, By Type
Figure 6: Products: Average Per Capita Consumption, By Type
Figure 7: Products: Exports And Growth, By Type
Figure 8: Products: Export Prices And Growth, By Type
Figure 9: Production Volume And Growth
Figure 10: Exports And Growth
Figure 11: Export Prices And Growth
Figure 12: Market Size And Growth
Figure 13: Per Capita Consumption
Figure 14: Imports And Growth
Figure 15: Import Prices
Figure 16: Production, In Physical Terms, 2007–2017
Figure 17: Production, In Value Terms, 2007–2017
Figure 18: Production, By Country, 2017
Figure 19: Production, In Physical Terms, By Country, 2007–2017
Figure 20: Imports, In Physical Terms, 2007–2017
Figure 21: Imports, In Value Terms, 2007–2017
Figure 22: Imports, In Physical Terms, By Country, 2017
Figure 23: Imports, In Physical Terms, By Country, 2007–2017
Figure 24: Imports, In Value Terms, By Country, 2007–2017
Figure 25: Import Prices, By Country, 2007–2017
Figure 26: Exports, In Physical Terms, 2007–2017
Figure 27: Exports, In Value Terms, 2007–2017
Figure 28: Exports, In Physical Terms, By Country, 2017
Figure 29: Exports, In Physical Terms, By Country, 2007–2017
Figure 30: Exports, In Value Terms, By Country, 2007–2017
Figure 31: Export Prices, 2007–2017